With an upside potential of 21.26% as of May 3, Merck & Co., Inc. (NYSE:MRK) is included among the 10 Best Fortune 500 Stocks ...

Merck (NYSE:MRK | MRK Price Prediction) delivered its fourth consecutive earnings beat, but shares slipped on the earnings ...

Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Merck’s widely used immunotherapy, Keytruda, drove the company’s topline growth during the quarter, accounting for nearly ...

Merck stock shows a confirmed double top breakdown, signaling potential downside risk, while key moving averages and ...

Looking ahead to 2030, our model projects MRK could trade at an average price of $178.66, with a potential range between $133.99 and $223.32. This represents a potential 59.3% return from today's ...

Merck’s MRK stock has risen 11% so far this year. Merck’s strong financial performance, positive clinical data, and improving ...

Merck (MRK) closed at $120.15 in the latest trading session, marking a -1.05% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 1.02%. Elsewhere, the Dow saw an ...

Merck faces falling sales for its key drugs including a blockbuster HPV vaccine and diabetes medication.